Skip to main content
. 2010 Autumn;9(4):451–457.

Table 3.

AVF patency rate according to underlying disease in aspirin, dipyridamol and control groups

AVF patency in each underlying disease aspirin (%) p - value dipyridamol (%) p-value control (%)
DM 14/20 (70%) 0.9531 28/35 (80%) 0.5065 29/41 (70.7%)
HTN 21/33 (63.6%) 0.5911 30/38 (78.9%) 0.6486 31/43 (72.1%)
HTN+DM 29/45 (64.4%) 0.7958 22/36 (61.1%) 0.8386 17/29 (58.6%)